Nerve growth factor evokes hyperalgesia in mice lacking the low-affinity neurotrophin receptor p75

Neuroscience Letters

Volumn 255, Issue 2, 1998, Pages 87-90

  Bergmann, Ilka ^a   Reiter, Rudolf ^b   Toyka, Klaus V ^a   Koltzenburg, Martin ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b ROCHE DIAGNOSTICS GMBH   (Germany)

Author keywords

Inflammation; Nociceptor; Pain; Peripheral nervous system; TNF ; trkA

Indexed keywords

NERVE GROWTH FACTOR; NEUROTROPHIN RECEPTOR; RECEPTOR SUBTYPE;

ANIMAL EXPERIMENT; ARTICLE; HYPERALGESIA; INFLAMMATION; MOUSE; NOCICEPTION; NONHUMAN; PAIN; PRIORITY JOURNAL; RECEPTOR AFFINITY; TRANSGENIC MOUSE;

ANIMALS; HEAT; HUMANS; HYPERALGESIA; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; NERVE GROWTH FACTORS; PAIN MEASUREMENT; PHYSICAL STIMULATION; RECEPTOR, NERVE GROWTH FACTOR; RECEPTORS, NERVE GROWTH FACTOR; RECOMBINANT PROTEINS; REFERENCE VALUES;

EID: 0032475465     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(98)00713-7     Document Type: Article

References (24)

1. Andreev N.Y., Dimitrieva N., Koltzenburg M., McMahon M. Peripheral administration of nerve growth factor in the adult rat requires the presence of sympathetic postganglionic neurones. Pain. 63:1995;109-115.
2. Apfel S.C., Arezzo J.C., Brownlee M., Federoff H., Kessler J.A. Nerve growth factor administration protects against experimental diabetic sensory neuropathy. Brain Res. 634:1994;7-12.
3. Apfel S.C., Arezzo J.C., Lipson L., Kessler J.A. Nerve growth factor prevents experimental cisplatin neuropathy. Ann. Neurol. 31:1992;76-80.
4. Apfel S.C., Lipton R.B., Arezzo J.C., Kessler J.A. Nerve growth factor prevents toxic neuropathy in mice. Ann. Neurol. 29:1991;87-90.
5. Barbacid M. The Trk family of neurotrophin receptors. J. Neurobiol. 25:1994;1386-1403.
6. Battleman D.S., Geller A.I., Chao M.V. HSV-1 vector-mediated gene transfer of the human nerve growth factor receptor p75hNGFR defines high-affinity NGF binding. J. Neurosci. 13:1993;941-951.
7. Benedetti M., Levi A., Chao M.V. Differential expression of nerve growth factor receptors leads to altered binding affinity and neurotrophin responsiveness. Proc. Natl. Acad. Sci. USA. 90:1993;7859-7863.
8. Bergmann I., Priestley J.V., McMahon S.B., Bröcker E.-B., Toyka K.V., Koltzenburg M. Analysis of cutaneous sensory neurons in transgenic mice lacking the low affinity neurotrophin receptor p75. Eur. J. Neurosci. 9:1997;18-28.
9. Carter B.D., Kaltschmidt C., Kaltschmidt B., Offenhauser N., Bohm Matthaei R., Baeuerle P.A., Barde Y.A. Selective activation of NF-kappa B by nerve growth factor through the neurotrophin receptor p75 (see comments). Science. 272:1996;542-545.
10. Casaccia-Bonnefil P., Carter B.D., Dobrowsky R.T., Chao M. Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75. Nature. 383:1996;716-719.
11. Diamond J., Holmes M., Coughlin M. Endogenous NGF and nerve impulses regulate the collateral sprouting of sensory axons in the skin of the adult rat. J. Neurosci. 12:1992;1454-1466.
12. Dobrowsky R.T., Werner M.H., Castellino A.M., Chao M.V., Hannun Y.A. Activation of the sphingomyelin cycle through the low-affinity neurotrophin receptor. Science. 265:1994;1596-1599.
13. Fernyhough P., Diemel L.T., Hardy J., Brewster W.J., Mohiuddin L., Tomlinson D.R. Human recombinant nerve growth factor replaces deficient neurotrophic support in the diabetic rat. Eur. J. Neurosci. 7:1995;1107-1110.
14. Koltzenburg M., Reiter R., Toyka K.V. Treatment with recombinant human nerve growth factor (rh NGF) normalises the small fibre neuropathy in STZ diabetic rats. J. Neurol. Suppl. 243:1996;S4.
15. Koltzenburg M., Stucky C.L., Lewin G.R. Receptive properties of mouse sensory neurons innervating hairy skin. J. Neurophysiol. 78:1997;1841-1850.
16. Lee K.F., Li E., Huber L.J., Landis S.C., Sharpe A.H., Chao M.V., Jaenisch R. Targeted mutation of the gene encoding the low affinity NGF receptor p75 leads to deficits in the peripheral sensory nervous system. Cell. 69:1992;737-749.
17. Lewin G.R., Barde Y.-A. Physiology of the neurotrophins. Ann. Rev. Neurol. 19:1996;289-317.
18. Lewin G.R., Mendell L.M. Nerve growth factor and nociception. Trends Neurosci. 16:1993;353-359.
19. Meakin S.O., Shooter E.M. The nerve growth factor family of receptors. Trends Neurosci. 15:1992;323-331.
20. Näher-Noé M., Gnahn H., Grundler A., Klingelhöfer J., Weindl A., Conrad B. Determination of nerve growth factor concentrations in human samples by two-site immunoenzymometric assay and bioassay. Eur. J. Clin. Chem. Clin. Biochem. 31:1993;375-380.
21. Petersen M., Segond von Banchet G., Heppelmann B., Koltzenburg M. The neurotrophin receptor p75 is involved in the regulation of bradykinin binding sites in cultured mouse sensory neurons. Neuroscience. 83:1998;161-168.
22. Petty B.G., Cornblath D.R., Adornato B.T., Chaudhry V., Flexner C., Wachsman M., Sinicropi D., Burton L.E., Peroutka S.J. The effect of systemically administered recombinant human nerve growth factor in healthy human subjects. Ann. Neurol. 36:1994;244-246.
23. Snider W.D. Functions of the neurotrophins during nervous system development: what the knockouts are teaching us. Cell. 77:1994;627-638.
24. Stucky C.L., Koltzenburg M. The low affinity neurotrophin receptor p75 regulates the function but not the selective survival of specific subpopulations of sensory neurons. J. Neurosci. 17:1997;4398-4405.